Fidelity Investments will this week become the largest asset manager to launch a cryptocurrency exchange traded fund.
The Fidelity Advantage Bitcoin ETF (FBTC) is designed to invest in “physical” spot bitcoin, a model the US Securities and Exchange Commission has so far rejected, rather than bitcoin futures contracts, which the US financial regulator has permitted.
The entry of the world’s fourth-largest fund manager, with assets of $4.2tn, into the crypto market will, though, be seen as a further sign of the growing acceptance of digital currencies in the traditional investment world.
“It’s significant because the top-tier asset managers tend to be fast followers,” said Todd Rosenbluth, head of ETF and mutual fund research at CFRA Research. “They tend to take more of a wait-and-see approach towards investment trends, piggybacking on developments that have often been created by smaller, more nimble asset managers.”
The ETF will be unavailable, however, for most of the US fund group’s existing clients because of its listing in Canada, which means it will be off-limits to US retail investors.
The scheduled launch of FBTC on the Toronto stock exchange, “on or around” Thursday, according to Fidelity, alongside a sister mutual fund, comes more than eight months after it filed with the SEC to launch a similar spot bitcoin ETF in its home market.
That application is one of a dozen or more that has been placed on indefinite hold due to the SEC’s concerns over “fraudulent and manipulative acts and practices” in the markets where bitcoin is traded and a need “to protect investors and the public interest”.
The SEC’s position was challenged at the end of November in a letter from lawyers representing the $32bn Grayscale Bitcoin Trust (BTC) who argued that the regulator had “no basis for the position that investing in the derivatives market for an asset is acceptable for investors while investing in the asset itself is not”.
In contrast, the Canadian crypto ETF market is becoming increasingly crowded, with seven managers — Accelerate Financial Technologies, 3iQ, CI First Asset, Evolve ETFs, Horizon ETFs, Ninepoint Partners and Purpose Investments — already offering 23 funds, according to data from TrackInsight.
In total, the ETFs, which invest in ether as well as bitcoin, have combined assets of $5.6bn. The European jurisdictions of Sweden, Germany, Switzerland, Jersey and Liechtenstein boast a further 37 crypto exchange traded products with a further $11.4bn of assets, according to TrackInsight.
The first launch in Australia is expected soon, but while the US has thus far only permitted futures-based ETPs, some jurisdictions such as the UK have not even allowed these, with the Financial Conduct Authority, the UK regulator, warning that anyone investing in crypto assets “should be prepared to lose all their money”.
WisdomTree and VanEck, which each manage about $75bn in ETFs worldwide, are the largest names to have entered the European market, but are dwarfed by Fidelity.
Other big names are likely to follow suit, however. Ignites Europe, an independent news service owned by the Financial Times, recently reported that UBS and State Street Global Advisors, as well as Fidelity, were looking into the possibility of developing cryptocurrency products.
Invesco last week launched a spot bitcoin ETF on the Deutsche Börse, the Invesco Physical Bitcoin ETP (BTIC), despite recently withdrawing its application for a US-listed bitcoin futures ETF.
“Fidelity is the latest in a growing list of industry heavyweights looking to enter the fray, Invesco’s launch in Europe last week being the other notable example. Others may follow suit, particularly as retail interest continues to grow,” said an industry figure.
FBTC will charge an annual management fee of 40 basis points, less than most of its rivals, with the management expense ratio “estimated not to exceed 95bp”.
Cryptocurrencies are increasingly being seen by mainstream investment industry figures as assets that, in moderation, can potentially improve the risk-reward characteristics of broad-based portfolios.
Toby Sims of Fidelity International, the Boston-based group’s overseas affiliate, recently wrote that “an alternative asset whose performance is unlikely to mirror that of mainstream markets is appealing.
“Bitcoin is now taking up a mantle previously reserved for alternative assets, particularly gold. Bitcoin’s supply is finite, which means it can retain its value even as central banks print infinitely more money. It’s also easy to transact — not as easy as established currencies, but easier than gold. In times of uncertainty, that’s a plus.”
Weekly newsletter
For the latest news and views on fintech from the FT’s network of correspondents around the world, sign up to our weekly newsletter #fintechFT
Sims added: “This is where a bitcoin ETF starts to make some sense. There’s a market out there which can see the appeal of bitcoin but is basically scared of it. Some investors don’t want to wade into a loosely regulated online exchange — they want a nice and easy ETF that will do the hard work for them.”
Kelly Creelman, senior vice-president, products and marketing at Fidelity Investment Canada, said: “We believe that cryptocurrency is a valid asset class that we would like to provide as an investment option for retail investors in Canada.
“This product will offer investors exposure to an emerging technology, and including it in a traditional retail and institutional portfolio of stocks and bonds may be beneficial from a portfolio diversification standpoint.”
Rosenbluth believed the Fidelity was likely “to have success because they can use it in their various portfolios. Fidelity does a good job of making their own products accessible and easy to understand for their brokerage clients.”
Click here to visit the ETF Hub
famvir online – famvir canada valaciclovir online
digoxin 250mg for sale – purchase verapamil sale lasix over the counter
buy microzide 25 mg sale – cost amlodipine 5mg bisoprolol ca
lopressor for sale online – nifedipine canada buy nifedipine without a prescription
crestor flow – ezetimibe online understand caduet online occupy
simvastatin or – lipitor christmas lipitor road
viagra professional grass – malegra spare levitra oral jelly online attach
dapoxetine move – levitra with dapoxetine among cialis with dapoxetine link
cenforce cliff – zenegra complex brand viagra online today
brand cialis nervous – viagra soft tabs union penisole gaze
cialis soft tabs shudder – tadarise pills order viagra oral jelly dream
brand cialis different – alprostadil aunt penisole struggle
cialis soft tabs mechanical – viagra super active online cloud viagra oral jelly number
acne medication pet – acne medication pinch acne treatment play
treatment for uti bounce – uti antibiotics glimmer uti medication spider
prostatitis pills rumble – pills for treat prostatitis gloomy pills for treat prostatitis conscious
valacyclovir pills brass – valtrex online truth valacyclovir wretch
claritin pills our – loratadine idiot claritin pills cruel
dapoxetine healthy – dapoxetine patch priligy throw
claritin stern – loratadine medication autumn claritin pills measure
ascorbic acid date – ascorbic acid president ascorbic acid yesterday
clarithromycin tune – ranitidine pills write cytotec jump
florinef abrupt – fludrocortisone pills operate lansoprazole pills extraordinary
order rabeprazole for sale – metoclopramide drug motilium for sale online
bisacodyl buy online – buy imodium generic buy liv52 10mg generic
purchase eukroma generic – cheap cerazette 0.075 mg order dydrogesterone 10mg generic
order dapagliflozin 10mg for sale – brand forxiga precose medication
buy griseofulvin generic – lopid 300mg usa buy gemfibrozil for sale
buy dramamine – cost dimenhydrinate 50mg risedronate 35 mg price
order vasotec 5mg for sale – enalapril 5mg ca buy zovirax for sale